Best of Oncology West Conference 2026
Friday, January 23, 2026
Event Landscape
The Best of Oncology West 2026 Virtual Conference will provide a comprehensive overview of the most impactful and practice-changing clinical developments in oncology presented throughout 2025. Focused on delivering the latest evidence across a broad spectrum of tumour sites, this highly anticipated event will feature expert-led discussions and critical analysis of key data and emerging trends.
Chaired by two of Western Canada’s leading medical oncologists, Dr. Sharlene Gill and Dr. Daniel Heng, the conference will convene a distinguished faculty of oncology experts from across the region. Together, they will examine how recent advancements are influencing current standards of care and shaping the future of cancer management. Designed for oncology professionals, this virtual program offers an essential opportunity to stay current with the evolving oncology landscape and apply the latest knowledge to clinical practice.
Learning Objectives
- Analyze pivotal clinical trials presented in 2025 across a range of tumour sites, with a focus on their impact on current and future oncology practice.
- Review the latest evidence-based standards of care for major malignancies, ensuring alignment with current treatment guidelines and best practices.
- Explore ongoing controversies and evolving perspectives in the management of select cancers, fostering critical discussion and expert insight.
Event Co-Chairs
Dr. Sharlene Gill
MD, MPH, MBA, FACP, FRCP(C), FASCO
Dr. Gill is a Professor of Medicine at the University of British Columbia and a medical oncologist specializing in gastrointestinal (GI) malignancies at BC Cancer – Vancouver. She received a Bachelor’s of Science in Pharmacy and an MD from the University of British Columbia in 1996 followed by residencies in Internal Medicine and Medical Oncology. Dr. Gill subsequently completed a fellowship in Gl Oncology at the Mayo Clinic (Rochester, MN) and a Master’s of Public Health from the Harvard School of Public Health. In 2017, she completed an MBA from the Kenan-Flagler School of Business at the University of North Carolina. She is actively engaged in education and research, with over 100 peer-reviewed publications and book chapters to her credit. Dr. Gill currently serves as the Chair of the Canadian Clinical Trials Group (CCTG) GI Disease Site Committee, and is President-Elect for the Canadian Association of Medical Oncologists.
Dr. Daniel Heng
MD, MPH, FRCPC
Dr. Daniel Heng is the Head of Medical Oncology attheArthur J.E. Child Comprehensive Cancer Centre in Calgary, Canada and a Clinical Professor of Medicine at the University of Calgary. He is the Chair of the International mRCC Consortium Database (www.IMDConline.com) which is the largest database of patients with metastatic kidney cancer treated with contemporary therapies in the world. The IMDC criteria (aka Heng Criteria) are used for kidney cancer prognostication. He has a keen interest in outcomes, prognostic factors and clinical trials research in metastatic renal cell carcinoma and other genitourinary malignancies. He was awarded the Meritorious Service Cross by the Governor General of Canada for his work in Kidney Cancer.
Sponsorship
For sponsorship-related inquiries, please contact your Director of Strategic Partnerships or visit our website
PLATINUM SPONSORS
All sales are final, refunds will not be accepted.
Please note mdBriefCase Group Inc. O/A Oncology Education cannot provide visa support for event attendees, including letters of invitation. Event attendees are solely responsible for obtaining any necessary documentation required for travel and participation in the event. No refunds shall be provided to individuals who are unable to attend.
Please be advised that video and photo recording will take place during this event. By registering and attending, you consent to being photographed and filmed. These materials may be used for promotional purposes, including but not limited to social media, websites, and other communication channels. If you have any concerns or wish to discuss this further, please contact us at [email protected] before the event.
